Oral Rotavirus Vaccine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Oral Rotavirus Vaccine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Oral Rotavirus Vaccine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Global Oral Rotavirus Vaccine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Oral Rotavirus Vaccine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou Lamb
Global Oral Rotavirus Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Vaccination Station
Other
Global Oral Rotavirus Vaccine Market: Manufacturers Segment Analysis (Company and Product introduction, Oral Rotavirus Vaccine Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi-Pasteur
Merck
CSL Biotherapies
LG Life Sciences
Crucell
China National Biotec Group
Hualan Biological Engineering
Sinovac Biotech
Dalian Hissen Bio-pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oral Rotavirus Vaccine-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Oral Rotavirus Vaccine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
- Worldwide and Top 20 Countries Market Size of Oral Rotavirus Vaccine 2013-2017, and development forecast 2018-2023
- Main manufacturers/suppliers of Oral Rotavirus Vaccine worldwide and market share by regions, with company and product introduction, position in the Oral Rotavirus Vaccine market
- Market status and development trend of Oral Rotavirus Vaccine by types and applications
- Cost and profit status of Oral Rotavirus Vaccine, and marketing status
- Market growth drivers and challenges
Global Oral Rotavirus Vaccine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Oral Rotavirus Vaccine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou Lamb
Global Oral Rotavirus Vaccine Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Vaccination Station
Other
Global Oral Rotavirus Vaccine Market: Manufacturers Segment Analysis (Company and Product introduction, Oral Rotavirus Vaccine Sales Volume, Revenue, Price and Gross Margin):
GSK
Sanofi-Pasteur
Merck
CSL Biotherapies
LG Life Sciences
Crucell
China National Biotec Group
Hualan Biological Engineering
Sinovac Biotech
Dalian Hissen Bio-pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORAL ROTAVIRUS VACCINE
1.1 Definition of Oral Rotavirus Vaccine in This Report
1.2 Commercial Types of Oral Rotavirus Vaccine
1.2.1 Rotarix
1.2.2 RotaTeq
1.2.3 Rotavac
1.2.4 Rotavin-M1
1.2.5 Lanzhou Lamb
1.3 Downstream Application of Oral Rotavirus Vaccine
1.3.1 Hospital
1.3.2 Vaccination Station
1.3.3 Other
1.4 Development History of Oral Rotavirus Vaccine
1.5 Market Status and Trend of Oral Rotavirus Vaccine 2013-2023
1.5.1 Global Oral Rotavirus Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Oral Rotavirus Vaccine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Oral Rotavirus Vaccine 2013-2017
2.2 Sales Market of Oral Rotavirus Vaccine by Regions
2.2.1 Sales Volume of Oral Rotavirus Vaccine by Regions
2.2.2 Sales Value of Oral Rotavirus Vaccine by Regions
2.3 Production Market of Oral Rotavirus Vaccine by Regions
2.4 Global Market Forecast of Oral Rotavirus Vaccine 2018-2023
2.4.1 Global Market Forecast of Oral Rotavirus Vaccine 2018-2023
2.4.2 Market Forecast of Oral Rotavirus Vaccine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Oral Rotavirus Vaccine by Types
3.2 Sales Value of Oral Rotavirus Vaccine by Types
3.3 Market Forecast of Oral Rotavirus Vaccine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Oral Rotavirus Vaccine by Downstream Industry
4.2 Global Market Forecast of Oral Rotavirus Vaccine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Oral Rotavirus Vaccine Market Status by Countries
5.1.1 North America Oral Rotavirus Vaccine Sales by Countries (2013-2017)
5.1.2 North America Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
5.1.3 United States Oral Rotavirus Vaccine Market Status (2013-2017)
5.1.4 Canada Oral Rotavirus Vaccine Market Status (2013-2017)
5.1.5 Mexico Oral Rotavirus Vaccine Market Status (2013-2017)
5.2 North America Oral Rotavirus Vaccine Market Status by Manufacturers
5.3 North America Oral Rotavirus Vaccine Market Status by Type (2013-2017)
5.3.1 North America Oral Rotavirus Vaccine Sales by Type (2013-2017)
5.3.2 North America Oral Rotavirus Vaccine Revenue by Type (2013-2017)
5.4 North America Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Oral Rotavirus Vaccine Market Status by Countries
6.1.1 Europe Oral Rotavirus Vaccine Sales by Countries (2013-2017)
6.1.2 Europe Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
6.1.3 Germany Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.4 UK Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.5 France Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.6 Italy Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.7 Russia Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.8 Spain Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.9 Benelux Oral Rotavirus Vaccine Market Status (2013-2017)
6.2 Europe Oral Rotavirus Vaccine Market Status by Manufacturers
6.3 Europe Oral Rotavirus Vaccine Market Status by Type (2013-2017)
6.3.1 Europe Oral Rotavirus Vaccine Sales by Type (2013-2017)
6.3.2 Europe Oral Rotavirus Vaccine Revenue by Type (2013-2017)
6.4 Europe Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Oral Rotavirus Vaccine Market Status by Countries
7.1.1 Asia Pacific Oral Rotavirus Vaccine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
7.1.3 China Oral Rotavirus Vaccine Market Status (2013-2017)
7.1.4 Japan Oral Rotavirus Vaccine Market Status (2013-2017)
7.1.5 India Oral Rotavirus Vaccine Market Status (2013-2017)
7.1.6 Southeast Asia Oral Rotavirus Vaccine Market Status (2013-2017)
7.1.7 Australia Oral Rotavirus Vaccine Market Status (2013-2017)
7.2 Asia Pacific Oral Rotavirus Vaccine Market Status by Manufacturers
7.3 Asia Pacific Oral Rotavirus Vaccine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Oral Rotavirus Vaccine Sales by Type (2013-2017)
7.3.2 Asia Pacific Oral Rotavirus Vaccine Revenue by Type (2013-2017)
7.4 Asia Pacific Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Oral Rotavirus Vaccine Market Status by Countries
8.1.1 Latin America Oral Rotavirus Vaccine Sales by Countries (2013-2017)
8.1.2 Latin America Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
8.1.3 Brazil Oral Rotavirus Vaccine Market Status (2013-2017)
8.1.4 Argentina Oral Rotavirus Vaccine Market Status (2013-2017)
8.1.5 Colombia Oral Rotavirus Vaccine Market Status (2013-2017)
8.2 Latin America Oral Rotavirus Vaccine Market Status by Manufacturers
8.3 Latin America Oral Rotavirus Vaccine Market Status by Type (2013-2017)
8.3.1 Latin America Oral Rotavirus Vaccine Sales by Type (2013-2017)
8.3.2 Latin America Oral Rotavirus Vaccine Revenue by Type (2013-2017)
8.4 Latin America Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Oral Rotavirus Vaccine Market Status by Countries
9.1.1 Middle East and Africa Oral Rotavirus Vaccine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
9.1.3 Middle East Oral Rotavirus Vaccine Market Status (2013-2017)
9.1.4 Africa Oral Rotavirus Vaccine Market Status (2013-2017)
9.2 Middle East and Africa Oral Rotavirus Vaccine Market Status by Manufacturers
9.3 Middle East and Africa Oral Rotavirus Vaccine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Oral Rotavirus Vaccine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Oral Rotavirus Vaccine Revenue by Type (2013-2017)
9.4 Middle East and Africa Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ORAL ROTAVIRUS VACCINE
10.1 Global Economy Situation and Trend Overview
10.2 Oral Rotavirus Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 11 ORAL ROTAVIRUS VACCINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Oral Rotavirus Vaccine by Major Manufacturers
11.2 Production Value of Oral Rotavirus Vaccine by Major Manufacturers
11.3 Basic Information of Oral Rotavirus Vaccine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Oral Rotavirus Vaccine Major Manufacturer
11.3.2 Employees and Revenue Level of Oral Rotavirus Vaccine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ORAL ROTAVIRUS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 GSK
12.1.1 Company profile
12.1.2 Representative Oral Rotavirus Vaccine Product
12.1.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of GSK
12.2 Sanofi-Pasteur
12.2.1 Company profile
12.2.2 Representative Oral Rotavirus Vaccine Product
12.2.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sanofi-Pasteur
12.3 Merck
12.3.1 Company profile
12.3.2 Representative Oral Rotavirus Vaccine Product
12.3.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Merck
12.4 CSL Biotherapies
12.4.1 Company profile
12.4.2 Representative Oral Rotavirus Vaccine Product
12.4.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of CSL Biotherapies
12.5 LG Life Sciences
12.5.1 Company profile
12.5.2 Representative Oral Rotavirus Vaccine Product
12.5.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of LG Life Sciences
12.6 Crucell
12.6.1 Company profile
12.6.2 Representative Oral Rotavirus Vaccine Product
12.6.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Crucell
12.7 China National Biotec Group
12.7.1 Company profile
12.7.2 Representative Oral Rotavirus Vaccine Product
12.7.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of China National Biotec Group
12.8 Hualan Biological Engineering
12.8.1 Company profile
12.8.2 Representative Oral Rotavirus Vaccine Product
12.8.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Hualan Biological Engineering
12.9 Sinovac Biotech
12.9.1 Company profile
12.9.2 Representative Oral Rotavirus Vaccine Product
12.9.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sinovac Biotech
12.10 Dalian Hissen Bio-pharm
12.10.1 Company profile
12.10.2 Representative Oral Rotavirus Vaccine Product
12.10.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Dalian Hissen Bio-pharm
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL ROTAVIRUS VACCINE
13.1 Industry Chain of Oral Rotavirus Vaccine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ORAL ROTAVIRUS VACCINE
14.1 Cost Structure Analysis of Oral Rotavirus Vaccine
14.2 Raw Materials Cost Analysis of Oral Rotavirus Vaccine
14.3 Labor Cost Analysis of Oral Rotavirus Vaccine
14.4 Manufacturing Expenses Analysis of Oral Rotavirus Vaccine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Oral Rotavirus Vaccine in This Report
1.2 Commercial Types of Oral Rotavirus Vaccine
1.2.1 Rotarix
1.2.2 RotaTeq
1.2.3 Rotavac
1.2.4 Rotavin-M1
1.2.5 Lanzhou Lamb
1.3 Downstream Application of Oral Rotavirus Vaccine
1.3.1 Hospital
1.3.2 Vaccination Station
1.3.3 Other
1.4 Development History of Oral Rotavirus Vaccine
1.5 Market Status and Trend of Oral Rotavirus Vaccine 2013-2023
1.5.1 Global Oral Rotavirus Vaccine Market Status and Trend 2013-2023
1.5.2 Regional Oral Rotavirus Vaccine Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Oral Rotavirus Vaccine 2013-2017
2.2 Sales Market of Oral Rotavirus Vaccine by Regions
2.2.1 Sales Volume of Oral Rotavirus Vaccine by Regions
2.2.2 Sales Value of Oral Rotavirus Vaccine by Regions
2.3 Production Market of Oral Rotavirus Vaccine by Regions
2.4 Global Market Forecast of Oral Rotavirus Vaccine 2018-2023
2.4.1 Global Market Forecast of Oral Rotavirus Vaccine 2018-2023
2.4.2 Market Forecast of Oral Rotavirus Vaccine by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Oral Rotavirus Vaccine by Types
3.2 Sales Value of Oral Rotavirus Vaccine by Types
3.3 Market Forecast of Oral Rotavirus Vaccine by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Oral Rotavirus Vaccine by Downstream Industry
4.2 Global Market Forecast of Oral Rotavirus Vaccine by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Oral Rotavirus Vaccine Market Status by Countries
5.1.1 North America Oral Rotavirus Vaccine Sales by Countries (2013-2017)
5.1.2 North America Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
5.1.3 United States Oral Rotavirus Vaccine Market Status (2013-2017)
5.1.4 Canada Oral Rotavirus Vaccine Market Status (2013-2017)
5.1.5 Mexico Oral Rotavirus Vaccine Market Status (2013-2017)
5.2 North America Oral Rotavirus Vaccine Market Status by Manufacturers
5.3 North America Oral Rotavirus Vaccine Market Status by Type (2013-2017)
5.3.1 North America Oral Rotavirus Vaccine Sales by Type (2013-2017)
5.3.2 North America Oral Rotavirus Vaccine Revenue by Type (2013-2017)
5.4 North America Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Oral Rotavirus Vaccine Market Status by Countries
6.1.1 Europe Oral Rotavirus Vaccine Sales by Countries (2013-2017)
6.1.2 Europe Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
6.1.3 Germany Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.4 UK Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.5 France Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.6 Italy Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.7 Russia Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.8 Spain Oral Rotavirus Vaccine Market Status (2013-2017)
6.1.9 Benelux Oral Rotavirus Vaccine Market Status (2013-2017)
6.2 Europe Oral Rotavirus Vaccine Market Status by Manufacturers
6.3 Europe Oral Rotavirus Vaccine Market Status by Type (2013-2017)
6.3.1 Europe Oral Rotavirus Vaccine Sales by Type (2013-2017)
6.3.2 Europe Oral Rotavirus Vaccine Revenue by Type (2013-2017)
6.4 Europe Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Oral Rotavirus Vaccine Market Status by Countries
7.1.1 Asia Pacific Oral Rotavirus Vaccine Sales by Countries (2013-2017)
7.1.2 Asia Pacific Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
7.1.3 China Oral Rotavirus Vaccine Market Status (2013-2017)
7.1.4 Japan Oral Rotavirus Vaccine Market Status (2013-2017)
7.1.5 India Oral Rotavirus Vaccine Market Status (2013-2017)
7.1.6 Southeast Asia Oral Rotavirus Vaccine Market Status (2013-2017)
7.1.7 Australia Oral Rotavirus Vaccine Market Status (2013-2017)
7.2 Asia Pacific Oral Rotavirus Vaccine Market Status by Manufacturers
7.3 Asia Pacific Oral Rotavirus Vaccine Market Status by Type (2013-2017)
7.3.1 Asia Pacific Oral Rotavirus Vaccine Sales by Type (2013-2017)
7.3.2 Asia Pacific Oral Rotavirus Vaccine Revenue by Type (2013-2017)
7.4 Asia Pacific Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Oral Rotavirus Vaccine Market Status by Countries
8.1.1 Latin America Oral Rotavirus Vaccine Sales by Countries (2013-2017)
8.1.2 Latin America Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
8.1.3 Brazil Oral Rotavirus Vaccine Market Status (2013-2017)
8.1.4 Argentina Oral Rotavirus Vaccine Market Status (2013-2017)
8.1.5 Colombia Oral Rotavirus Vaccine Market Status (2013-2017)
8.2 Latin America Oral Rotavirus Vaccine Market Status by Manufacturers
8.3 Latin America Oral Rotavirus Vaccine Market Status by Type (2013-2017)
8.3.1 Latin America Oral Rotavirus Vaccine Sales by Type (2013-2017)
8.3.2 Latin America Oral Rotavirus Vaccine Revenue by Type (2013-2017)
8.4 Latin America Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Oral Rotavirus Vaccine Market Status by Countries
9.1.1 Middle East and Africa Oral Rotavirus Vaccine Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Oral Rotavirus Vaccine Revenue by Countries (2013-2017)
9.1.3 Middle East Oral Rotavirus Vaccine Market Status (2013-2017)
9.1.4 Africa Oral Rotavirus Vaccine Market Status (2013-2017)
9.2 Middle East and Africa Oral Rotavirus Vaccine Market Status by Manufacturers
9.3 Middle East and Africa Oral Rotavirus Vaccine Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Oral Rotavirus Vaccine Sales by Type (2013-2017)
9.3.2 Middle East and Africa Oral Rotavirus Vaccine Revenue by Type (2013-2017)
9.4 Middle East and Africa Oral Rotavirus Vaccine Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF ORAL ROTAVIRUS VACCINE
10.1 Global Economy Situation and Trend Overview
10.2 Oral Rotavirus Vaccine Downstream Industry Situation and Trend Overview
CHAPTER 11 ORAL ROTAVIRUS VACCINE MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Oral Rotavirus Vaccine by Major Manufacturers
11.2 Production Value of Oral Rotavirus Vaccine by Major Manufacturers
11.3 Basic Information of Oral Rotavirus Vaccine by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Oral Rotavirus Vaccine Major Manufacturer
11.3.2 Employees and Revenue Level of Oral Rotavirus Vaccine Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 ORAL ROTAVIRUS VACCINE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 GSK
12.1.1 Company profile
12.1.2 Representative Oral Rotavirus Vaccine Product
12.1.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of GSK
12.2 Sanofi-Pasteur
12.2.1 Company profile
12.2.2 Representative Oral Rotavirus Vaccine Product
12.2.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sanofi-Pasteur
12.3 Merck
12.3.1 Company profile
12.3.2 Representative Oral Rotavirus Vaccine Product
12.3.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Merck
12.4 CSL Biotherapies
12.4.1 Company profile
12.4.2 Representative Oral Rotavirus Vaccine Product
12.4.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of CSL Biotherapies
12.5 LG Life Sciences
12.5.1 Company profile
12.5.2 Representative Oral Rotavirus Vaccine Product
12.5.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of LG Life Sciences
12.6 Crucell
12.6.1 Company profile
12.6.2 Representative Oral Rotavirus Vaccine Product
12.6.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Crucell
12.7 China National Biotec Group
12.7.1 Company profile
12.7.2 Representative Oral Rotavirus Vaccine Product
12.7.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of China National Biotec Group
12.8 Hualan Biological Engineering
12.8.1 Company profile
12.8.2 Representative Oral Rotavirus Vaccine Product
12.8.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Hualan Biological Engineering
12.9 Sinovac Biotech
12.9.1 Company profile
12.9.2 Representative Oral Rotavirus Vaccine Product
12.9.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Sinovac Biotech
12.10 Dalian Hissen Bio-pharm
12.10.1 Company profile
12.10.2 Representative Oral Rotavirus Vaccine Product
12.10.3 Oral Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of Dalian Hissen Bio-pharm
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL ROTAVIRUS VACCINE
13.1 Industry Chain of Oral Rotavirus Vaccine
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF ORAL ROTAVIRUS VACCINE
14.1 Cost Structure Analysis of Oral Rotavirus Vaccine
14.2 Raw Materials Cost Analysis of Oral Rotavirus Vaccine
14.3 Labor Cost Analysis of Oral Rotavirus Vaccine
14.4 Manufacturing Expenses Analysis of Oral Rotavirus Vaccine
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
